Formulation Development of Parenteral Phospholipid-based Microemulsion of Etoposide
- 13 May 2010
- journal article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 11 (2) , 826-831
Abstract
The aim of the present study was to investigate the potential of a phospholipid-based microemulsion formulation for parenteral delivery of anticancer drug, etoposide. The microemulsion area was identified by constructing pseudoternary phase diagrams. The prepared microemulsions were subjected to different thermodynamic stability tests. The microemulsion formulations that passed thermodynamic stability tests were characterized for optical birefringence, droplet size, viscosity measurement, and pH measurements. To assess the safety of the formulations for parenteral delivery, the formulation was subjected to compatibility studies with various intravenous infusions and in vitro erythrocyte toxicity study. The developed formulation was found to be robust and safe for parenteral delivery.Keywords
This publication has 7 references indexed in Scilit:
- Parenteral microemulsions: An overviewInternational Journal of Pharmaceutics, 2008
- Stability and degradation kinetics of etoposide‐loaded parenteral lipid emulsionJournal of Pharmaceutical Sciences, 2007
- Solubilizing Excipients in Oral and Injectable FormulationsPharmaceutical Research, 2004
- A Novel Assay to Determine the Hemolytic Activity of Drugs Incorporated in Colloidal Carrier SystemsPharmaceutical Research, 1994
- Effects of Hydrotropic Agents on the Solubility, Precipitation, and Protein Binding of EtoposideJournal of Pharmaceutical Sciences, 1989
- The Possible use of Autoclaving Microemulsions for SterilizationDrug Development and Industrial Pharmacy, 1979
- Schulman's Microemulsions1977